A safety study done by the maker of the asthma drug omalizumab (Xolair) suggests it poses slightly increased but serious risks for heart attacks and mini-strokes known as TIAs (transient ischemic attacks), the FDA says.
Spotting cancer early is key, but trying to do that -- often when there are no symptoms -- has been challenging. Still, more and more evidence suggests that all cancers have a signature, or even a scent, that can be detected early.
The recent FDA approval of Trulicity, an injectable type 2 diabetes drug, gives people a third option when it comes to once-a-week diabetes medication. WebMD asked two doctors and a pharmacist familiar with the new medications to answer some commonly asked questions about the weekly options.
People who suffer from migraines with aura during middle age have double the risk of developing Parkinson's disease or other movement disorders later in life than those who do not, according to a study published Wednesday in the journal Neurology.
The majority of seven caregivers had success when using early behavioral modification techniques with their children who showed early signs of autism. Five of the seven showed no developmental problems after being a part of the study.
Soda makers want to cut the number of calories you're drinking each year. At the Clinton Global Initiative on Tuesday, the big three -- Coke, Pepsi and Dr. Pepper -- pledged to reduce the number of beverage calories Americans are consuming by 20% over the next decade.